Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06622070
PHASE1

A Study of SPY002-072 in Healthy Volunteers

Sponsor: Spyre Therapeutics, Inc.

View on ClinicalTrials.gov

Summary

This is a Phase 1, randomized, double-blind, placebo-controlled, single-dose, first in human safety, tolerability, and pharmacokinetic study of SPY002-072 in healthy participants.

Official title: A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of SPY002-072 in Healthy Participants

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

56

Start Date

2024-11-18

Completion Date

2026-08-08

Last Updated

2024-11-27

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

SPY002-072

Experimental

OTHER

Placebo

Placebo

Locations (2)

Spyre Site 2

Cypress, California, United States

Spyre Site 1

Montreal, Quebec, Canada